Search research articles
Contact Us
Filters
Showing results (181-190 of 195) with videos related to
Page
of 20
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 4, 2018
Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC
Annett Linge, Ulrike Schötz, Steffen Löck, et al.
Cancers
|
August 12, 2022
Integration of p16/HPV DNA Status with a 24-miRNA-Defined Molecular Phenotype Improves Clinically Relevant Stratification of Head and Neck Cancer Patients
Julia Hess, Kristian Unger, Cornelius Maihoefer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 18, 2023
The value of subcutaneous xenografts for individualised radiotherapy in HNSCC: Robust gene signature correlates with radiotherapy outcome in patients and xenografts
Annett Linge, Shivaprasad Patil, Marianne Grosser, et al.
The Pharmacogenomics Journal
|
October 3, 2020
Correction: ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
Maja Guberina, Ali Sak, Christoph Pöttgen, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
May 18, 2025
MicroRNA-mediated PTEN downregulation as a novel non-genetic mechanism of acquired resistance to PI3Kα inhibitors of head & neck squamous cell carcinoma
Claudio Pulito, Sebastiano Vaccarella, Alina Catalina Palcau, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 9, 2022
Analyses of molecular subtypes and their association to mechanisms of radioresistance in patients with HPV-negative HNSCC treated by postoperative radiochemotherapy
Shivaprasad Patil, Bouchra Tawk, Marianne Grosser, et al.
Cancer Treatment Reviews
|
June 28, 2026
Standardization of objectives and response criteria for neoadjuvant immunotherapy in resectable squamous cell carcinoma of the head and neck
Carlo Resteghini, Athanassios Argiris, Pierre Blanchard, et al.
The Pharmacogenomics Journal
|
June 18, 2020
ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
Maja Guberina, Ali Sak, Christoph Pöttgen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 5, 2018
Development and Validation of a Gene Signature for Patients with Head and Neck Carcinomas Treated by Postoperative Radio(chemo)therapy
Stefan Schmidt, Annett Linge, Alex Zwanenburg, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 11, 2026
A tumor DNA-Methylome derived signature of Hypoxia Identifies HPV-negative head and neck cancer patients at risk for distant metastasis after postoperative radiochemotherapy (PORT-C)
Bouchra Tawk, Gordana Halec, Katrin Rein, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 195) with videos related to
Sort By:
Page
of 20
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 4, 2018
Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC
Annett Linge, Ulrike Schötz, Steffen Löck, et al.
Cancers
|
August 12, 2022
Integration of p16/HPV DNA Status with a 24-miRNA-Defined Molecular Phenotype Improves Clinically Relevant Stratification of Head and Neck Cancer Patients
Julia Hess, Kristian Unger, Cornelius Maihoefer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 18, 2023
The value of subcutaneous xenografts for individualised radiotherapy in HNSCC: Robust gene signature correlates with radiotherapy outcome in patients and xenografts
Annett Linge, Shivaprasad Patil, Marianne Grosser, et al.
The Pharmacogenomics Journal
|
October 3, 2020
Correction: ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
Maja Guberina, Ali Sak, Christoph Pöttgen, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
May 18, 2025
MicroRNA-mediated PTEN downregulation as a novel non-genetic mechanism of acquired resistance to PI3Kα inhibitors of head & neck squamous cell carcinoma
Claudio Pulito, Sebastiano Vaccarella, Alina Catalina Palcau, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 9, 2022
Analyses of molecular subtypes and their association to mechanisms of radioresistance in patients with HPV-negative HNSCC treated by postoperative radiochemotherapy
Shivaprasad Patil, Bouchra Tawk, Marianne Grosser, et al.
Cancer Treatment Reviews
|
June 28, 2026
Standardization of objectives and response criteria for neoadjuvant immunotherapy in resectable squamous cell carcinoma of the head and neck
Carlo Resteghini, Athanassios Argiris, Pierre Blanchard, et al.
The Pharmacogenomics Journal
|
June 18, 2020
ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
Maja Guberina, Ali Sak, Christoph Pöttgen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 5, 2018
Development and Validation of a Gene Signature for Patients with Head and Neck Carcinomas Treated by Postoperative Radio(chemo)therapy
Stefan Schmidt, Annett Linge, Alex Zwanenburg, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 11, 2026
A tumor DNA-Methylome derived signature of Hypoxia Identifies HPV-negative head and neck cancer patients at risk for distant metastasis after postoperative radiochemotherapy (PORT-C)
Bouchra Tawk, Gordana Halec, Katrin Rein, et al.
Page
of 20